Inotiv Inc (NOTV) Stock Price, Quote & News

Company Profile

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research cen...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 765 463 4527

Website: www.inotiv.com

Address:

2701 Kent Avenue, West Lafayette, United States

11thestate May. 19 at 2:16 PM

$NOTV investors, there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/inotiv-investor-settlement

0 · Reply

Sam201 May. 18 at 3:20 PM

$NOTV he has no skin here but cares so much? Read all filings so carefully. Sure 🤣. 35 cents? It was around 0.3 n with 90k shares it came to 0.26 ish. Big deal!! Load at these levels IMO! This maybe the last opportunity!

0 · Reply

bundy3333 May. 18 at 2:23 PM

$NOTV Just forget or block that Sam201 guy - already conspicuously preserved at board of e.g. MGRX 360.000 share owner and so on. I do not have any stake in NOTV, but I am confused about the share price today Do I understand correctly that NOTV took a loan of 27,5 million in order to achieve: Canceling the loans of 13.000 million and 410.000 USD plus fees of 13.410 million as specified in the 10-Q filing Plus getting cash in order to prove that the company has cash of the requested amount of at least 10.000 million (see recent 14-days waivers)? And why is that the share price reacts like this way - from 35 to 26 cent? Canceling

0 · Reply

focafoca99 May. 18 at 12:47 PM

$NOTV obtained a $40 million bridge facility under a Ninth Amendment to its credit agreement, borrowing $27.5 million to repay revolving

0 · Reply

Fares_Jordan May. 16 at 6:29 PM

$NOTV Is it possible for the stock to rise to $1 before the end of June?

0 · Reply

Sam201 May. 15 at 7:09 PM

$NOTV need more push… maybe

0 · Reply

topstockalerts May. 13 at 8:06 PM

$NOTV whoever wanted out appears to be out.

0 · Reply

Sam201 May. 13 at 6:53 PM

$NOTV hope you loaded this morning! Kept saying buy buy! $CDT is next!

0 · Reply

marvessa May. 13 at 6:30 PM

$NOTV market cap 10 Million is ridicolous

0 · Reply

Bgirl_smirk May. 13 at 6:06 PM

$NOTV 0.3133 close above and we go 0.43

0 · Reply

Inotiv Quarterly report: Q2 2026

2026-02-13T21:35:18.000Z - 3 months ago

Inotiv provides notice regarding cybersecurity incident

Feb 13, 2026, 4:30 PM EST - 3 months ago

Inotiv Provides Notice Regarding Cybersecurity Incident

2026-02-10T13:46:26.000Z - 3 months ago

Inotiv price target lowered to $1.50 from $3 at Lake Street

Feb 9, 2026, 3:00 PM EST - 3 months ago

Inotiv Slides: Investor presentation

Feb 9, 2026, 8:30 AM EST - 3 months ago

Inotiv Earnings Call Transcript: Q1 2026

Feb 9, 2026, 8:30 AM EST - 3 months ago

Inotiv Quarterly report: Q1 2026

Feb 9, 2026, 8:30 AM EST - 3 months ago

Inotiv Earnings release: Q1 2026

2026-02-09T12:05:07.000Z - 3 months ago

Inotiv reports Q1 EPS (83c) vs. ($1.02) last year

Feb 9, 2026, 7:00 AM EST - 3 months ago

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Feb 4, 2026, 6:30 AM EST - 3 months ago

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

2026-01-13T14:25:41.000Z - 4 months ago

Inotiv to leverage LifeNet Health’s TruVivo in translational drug discovery

Jan 13, 2026, 9:15 AM EST - 4 months ago

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

2025-12-11T14:05:20.000Z - 5 months ago

Inotiv partners with Vugene to advance AI-driven drug discovery

Dec 11, 2025, 9:00 AM EST - 5 months ago

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

2025-12-04T13:50:53.000Z - 6 months ago

Inotiv price target lowered to $3 from $5 at Lake Street

Dec 3, 2025, 4:30 PM EST - 6 months ago

Inotiv Earnings Call Transcript: Q4 2025

Dec 3, 2025, 4:30 PM EST - 6 months ago

Inotiv Annual report: Q4 2025

Dec 3, 2025, 4:30 PM EST - 6 months ago

Inotiv Earnings release: Q4 2025

Dec 3, 2025, 4:05 PM EST - 6 months ago

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

Nov 25, 2025, 7:00 AM EST - 6 months ago

Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™

Nov 21, 2025, 7:00 AM EST - 6 months ago

Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

Nov 18, 2025, 11:00 AM EST - 6 months ago

Inotiv Transcript: Jefferies London Healthcare Conference 2025

2025-11-17T23:55:14.000Z - 6 months ago

Closing Bell Movers: Inotiv surges after quarterly results

APYX AXTA LFMD MRVI

2025-11-17T21:20:48.000Z - 6 months ago

Inotiv sees Q4 revenue $137.5M-$138.5M, consensus $133.35M

2025-11-17T21:20:30.000Z - 6 months ago

Inotiv sees FY25 revenue $512.5M-$513.5M, consensus $508.25M

Nov 17, 2025, 4:05 PM EST - 6 months ago

Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results

Oct 24, 2025, 10:20 AM EDT - 7 months ago

Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Sep 10, 2025, 1:00 PM EDT - 9 months ago

Inotiv Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 10, 2025, 1:00 PM EDT - 9 months ago

Inotiv Slides: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 12:50 PM EDT - 9 months ago

Inotiv Transcript: Baird Global Healthcare Conference 2025

2025-08-29T21:15:19.000Z - 9 months ago

Inotiv files $350M mixed securities shelf

Aug 29, 2025, 8:00 AM EDT - 9 months ago

Inotiv Registration statement: Registration Filing

2025-08-18T20:30:20.000Z - 9 months ago

Inotiv announces cybersecurity incident

2025-08-18T20:25:15.000Z - 9 months ago

Inotiv announces cybersecurity incident

Aug 13, 2025, 7:00 AM EDT - 10 months ago

Inotiv, Inc. to Participate in Three Investor Conferences in September 2025

Aug 6, 2025, 9:16 PM EDT - 10 months ago

CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Inotiv Earnings Call Transcript: Q3 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Inotiv Quarterly report: Q3 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Inotiv Earnings release: Q3 2025

Aug 6, 2025, 4:05 PM EDT - 10 months ago

Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update

Jul 23, 2025, 7:00 AM EDT - 10 months ago

Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025

Jun 4, 2025, 3:45 PM EDT - 1 year ago

Inotiv Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 10:00 AM EDT - 1 year ago

Inotiv Slides: FY 2025

May 22, 2025, 4:05 PM EDT - 1 year ago

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025

2025-05-08T13:25:01.000Z - 1 year ago

Inotiv price target lowered to $5 from $6 at Lake Street

May 8, 2025, 7:00 AM EDT - 1 year ago

Inotiv Slides: Investor Presentation

May 7, 2025, 4:30 PM EDT - 1 year ago

Inotiv Earnings Call Transcript: Q2 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Inotiv Quarterly report: Q2 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Inotiv Earnings release: Q2 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

Apr 23, 2025, 4:05 PM EDT - 1 year ago

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

2025-04-11T12:45:38.000Z - 1 year ago

Lake Street doesn’t expect Inotiv financial impact from FDA ‘headline noise’

2025-04-10T20:06:27.000Z - 1 year ago

Inotiv drops after FDA says phasing out animal testing of monoclonal antibodies

CRL

2025-04-07T09:50:44.000Z - 1 year ago

Sea Pharmaceuticals announces strategic relationship with Inotiv

2025-02-06T13:41:29.000Z - 1 year ago

Inotiv price target lowered to $9 from $10 at Craig-Hallum

Feb 5, 2025, 6:00 PM EST - 1 year ago

Inotiv Slides: Investor Presentation

2025-02-05T21:40:57.000Z - 1 year ago

Inotiv reports Q1 EPS ($1.02), consensus (42c)

Feb 5, 2025, 4:30 PM EST - 1 year ago

Inotiv Earnings Call Transcript: Q1 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Inotiv Quarterly report: Q1 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Inotiv Earnings release: Q1 2025

Jan 23, 2025, 7:00 AM EST - 1 year ago

Inotiv Proxy statement: Proxy Filing

Jan 23, 2025, 7:00 AM EST - 1 year ago

Inotiv Proxy statement: Proxy Filing

Jan 22, 2025, 4:05 PM EST - 1 year ago

Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

2025-01-17T13:50:45.000Z - 1 year ago

Cambodian NHP suspension neutral to positive for Inotiv, says Lake Street

Dec 30, 2024, 4:05 PM EST - 1 year ago

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

Dec 23, 2024, 4:05 PM EST - 1 year ago

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

2024-12-18T13:11:29.000Z - 1 year ago

Inotiv prices 6M shares at $4.25 in underwritten public offering

Dec 17, 2024, 4:03 PM EST - 1 year ago

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

Dec 6, 2024, 7:45 AM EST - 1 year ago

Inotiv Slides: Investor Presentation

Dec 3, 2024, 4:30 PM EST - 1 year ago

Inotiv Earnings Call Transcript: Q4 2024

Dec 3, 2024, 4:30 PM EST - 1 year ago

Inotiv Annual report: Q4 2024

Dec 3, 2024, 4:30 PM EST - 1 year ago

Inotiv Earnings release: Q4 2024

Dec 3, 2024, 4:05 PM EST - 1 year ago

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

Nov 21, 2024, 8:30 AM EST - 1 year ago

Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 20, 2024, 4:05 PM EST - 1 year ago

Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

Nov 18, 2024, 1:00 AM EST - 1 year ago

Inotiv Slides: Investor Presentation

Oct 3, 2024, 8:00 AM EDT - 1 year ago

Inotiv Registration statement: Registration Filing

Sep 16, 2024, 8:00 AM EDT - 1 year ago

Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity

Aug 28, 2024, 4:05 PM EDT - 1 year ago

Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Aug 16, 2024, 1:00 AM EDT - 1 year ago

Inotiv Slides: Investor Presentation

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Inotiv Earnings Call Transcript: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Inotiv Quarterly report: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Inotiv Earnings release: Q3 2024

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024

Jun 10, 2024, 7:30 AM EDT - 2 years ago

Inotiv, Inc. Provides Business Updates

Jun 6, 2024, 10:30 AM EDT - 2 years ago

Inotiv Transcript: Jefferies Global Healthcare Conference

Jun 3, 2024, 1:24 PM EDT - 2 years ago

Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility

May 23, 2024, 4:15 PM EDT - 2 years ago

Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences

May 17, 2024, 1:00 AM EDT - 2 years ago

Inotiv Slides: Investor Presentation

May 15, 2024, 4:30 PM EDT - 2 years ago

Inotiv Earnings Call Transcript: Q2 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Inotiv Quarterly report: Q2 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Inotiv Earnings release: Q2 2024

May 15, 2024, 4:05 PM EDT - 2 years ago

Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update

May 14, 2024, 7:00 AM EDT - 2 years ago

Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024

May 9, 2024, 6:56 PM EDT - 2 years ago

Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results

May 3, 2024, 2:35 PM EDT - 2 years ago

INOTIV INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inotiv, Inc. - NOTV

Apr 29, 2024, 4:05 PM EDT - 2 years ago

Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024

Apr 19, 2024, 10:45 PM EDT - 2 years ago

INOTIV INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inotiv, Inc. - NOTV

Feb 7, 2024, 4:30 PM EST - 2 years ago

Inotiv Earnings Call Transcript: Q1 2024

Feb 7, 2024, 4:30 PM EST - 2 years ago

Inotiv Quarterly report: Q1 2024

Feb 7, 2024, 4:30 PM EST - 2 years ago

Inotiv Earnings release: Q1 2024

Feb 7, 2024, 4:05 PM EST - 2 years ago

Inotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business Update

Feb 7, 2024, 1:00 AM EST - 2 years ago

Inotiv Slides: Investor Presentation

Jan 29, 2024, 4:05 PM EST - 2 years ago

Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024

Jan 26, 2024, 7:00 AM EST - 2 years ago

Inotiv Proxy statement: Proxy Filing

Jan 26, 2024, 7:00 AM EST - 2 years ago

Inotiv Proxy statement: Proxy Filing

Dec 12, 2023, 1:00 PM EST - 2 years ago

Inotiv Slides: Investor Presentation

Dec 11, 2023, 4:30 PM EST - 2 years ago

Inotiv Earnings Call Transcript: Q4 2023

Dec 11, 2023, 4:30 PM EST - 2 years ago

Inotiv Annual report: Q4 2023

Dec 11, 2023, 4:30 PM EST - 2 years ago

Inotiv Earnings release: Q4 2023

Dec 11, 2023, 4:05 PM EST - 2 years ago

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2023 and Provides Business Update

Dec 11, 2023, 1:00 AM EST - 2 years ago

Inotiv Slides: Investor Presentation

Dec 6, 2023, 4:30 PM EST - 2 years ago

Inotiv, Inc. Announces Plan to Insource North American Transportation Operations

Nov 29, 2023, 3:00 PM EST - 2 years ago

Inotiv Transcript: 6th Annual Evercore ISI HealthCONx Conference

Nov 27, 2023, 4:05 PM EST - 2 years ago

Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023

Nov 15, 2023, 11:00 AM EST - 2 years ago

Inotiv Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 13, 2023, 4:05 PM EST - 2 years ago

Inotiv Provides Business Updates and Upcoming Investor Conferences Update

Nov 13, 2023, 7:00 AM EST - 2 years ago

Inotiv Slides: Investor Presentation

Nov 8, 2023, 7:30 AM EST - 2 years ago

Inotiv Ranked Number 127 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Inotiv, Inc. to Participate in Upcoming Investor Conferences

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Inotiv, Inc. Announces Changes to its Board Composition

Oct 3, 2023, 1:00 PM EDT - 2 years ago

Inotiv Slides: Investor Presentation

Sep 8, 2023, 8:45 AM EDT - 2 years ago

Inotiv Transcript: Wells Fargo Securities Healthcare Conference 2023

Sep 7, 2023, 4:00 PM EDT - 2 years ago

Inotiv Slides: Investor Presentation

Sep 1, 2023, 4:00 PM EDT - 2 years ago

Inotiv Slides: Investor Presentation

Aug 29, 2023, 6:47 PM EDT - 2 years ago

Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.

Aug 24, 2023, 4:05 PM EDT - 2 years ago

Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences

11thestate May. 19 at 2:16 PM

0 · Reply

Sam201 May. 18 at 3:20 PM

0 · Reply

bundy3333 May. 18 at 2:23 PM

0 · Reply

focafoca99 May. 18 at 12:47 PM

$NOTV obtained a $40 million bridge facility under a Ninth Amendment to its credit agreement, borrowing $27.5 million to repay revolving

0 · Reply

Fares_Jordan May. 16 at 6:29 PM

$NOTV Is it possible for the stock to rise to $1 before the end of June?

0 · Reply

Sam201 May. 15 at 7:09 PM

$NOTV need more push… maybe

0 · Reply

topstockalerts May. 13 at 8:06 PM

$NOTV whoever wanted out appears to be out.

0 · Reply

Sam201 May. 13 at 6:53 PM

$NOTV hope you loaded this morning! Kept saying buy buy! $CDT is next!

0 · Reply

marvessa May. 13 at 6:30 PM

$NOTV market cap 10 Million is ridicolous

0 · Reply

Bgirl_smirk May. 13 at 6:06 PM

$NOTV 0.3133 close above and we go 0.43

0 · Reply

Bgirl_smirk May. 13 at 5:59 PM

$NOTV starter

0 · Reply

Sam201 May. 13 at 5:08 PM

$NOTV 😂! Laughing or crying. 😭 you will soon!

0 · Reply

RocketThief May. 13 at 5:05 PM

$NOTV oh I’m still laughing, pumper 🤡. Both at this stock and at your shameful attempts to get others to bail you out

0 · Reply

Sam201 May. 13 at 5:03 PM

$NOTV he was laughing yesterday 🤣😂

0 · Reply

RocketThief May. 13 at 4:47 PM

$NOTV you forgot to mention that this scandal-ridden company is almost completely out of cash and has over $410M of current debt.

0 · Reply

marvessa May. 13 at 3:24 PM

$NOTV looks interesting

0 · Reply

BullyingIsGood May. 13 at 3:11 PM

$NOTV I am in for a couple shares see how the ride is...

1 · Reply

LiveCommander May. 13 at 3:03 PM

Fun stock i just discovered No buy or sell suggestion but just something i have not seen before. $NOTV $0.25 a share Market cap: $9M $500M in revenue 😳 Expecting $1B in revenue in 2030. Analysis price target: $1.50 (500% up) Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Just never seen this before @LiveCommander $PLTR $WEN $WOLF

0 · Reply

PhotonicDigger May. 13 at 3:01 PM

$NOTV feels a bit “off narrative” Around $0.25 per share with a ~$9M market cap, yet revenue sits at a completely different scale. It operates in nonclinical drug development and testing — an under-the-radar but essential part of the pharma R&D chain. What stands out is the gap between how the market is pricing it and its actual operational footprint. So the question is: is this simply overlooked… or is the market pricing it that way for a reason? Free sharing and subscription 👉@PhotonicDigger.

0 · Reply

Sam201 May. 13 at 2:39 PM

$NOTV loaded 30k more to 280k shares!

0 · Reply

Sam201 May. 13 at 2:26 PM

$MGRX $NOTV this George excited every time this dips 10% 🤣😂.

0 · Reply

bundy3333 May. 13 at 12:45 PM

$MGRX User jirishman $NOTV

0 · Reply

Market Cap	9.11M
Revenue (ttm)	513.02M
Net Income (ttm)	-68.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-13.38%
Debt to Equity Ratio	5.49

Volume	222,544
Avg Vol	795,868
Day's Range	N/A - N/A
Shares Out	34.89M
Stochastic %K	38%
Beta	3.82
Analysts	Strong Sell
Price Target	$3.00